North Carolina § 90-325.6 No private right of action against manufacturers of investigational drugs, biological products, or devices

North Carolina Statutes

§ 90-325.6 — No private right of action against manufacturers of investigational drugs, biological products, or devices

North Carolina § 90-325.6

Ch. 90Medicine and Allied Occupations

Art. 23ARight to Try Act

This text of North Carolina § 90-325.6 (No private right of action against manufacturers of investigational drugs, biological products, or devices) is published on Counsel Stack Legal Research, covering North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.C. Gen. Stat. § 90-325.6 (2026).

Text

No private right of action may be brought against a manufacturer of an investigational drug, biological product, or device, or against any other person or entity involved in the care of an eligible patient using an investigational drug, biological product, or device, for any harm caused to the eligible patient resulting from use of the investigational drug, biological product, or device as long as the manufacturer or other person or entity has made a good-faith effort to comply with the provisions of this Part and has exercised reasonable care in actions undertaken pursuant to this Part. (2015-137, s. 1; 2019-70, s. 1.)

Free access — add to your briefcase to read the full text and ask questions with AI

No private right of action may be brought against a manufacturer of an investigational drug, biological product, or device, or against any other person or entity involved in the care of an eligible patient using an investigational drug, biological product, or device, for any harm caused to the eligible patient resulting from use of the investigational drug, biological product, or device as long as the manufacturer or other person or entity has made a good-faith effort to comply with the provisions of this Part and has exercised reasonable care in actions undertaken pursuant to this Part. (2015-137, s. 1; 2019-70, s. 1.)